13306 results for ""pdc"+"heritage+language"+census+study"

in 10.08 milliseconds.

• Dilgom_Exome

  The Finrisk sample sets are part of the National FINRISK Study. It is a large population survey on risk factors of chronic, noncommunicable diseases. The survey is carried out since 1972 every five years using independent, random and representative population samples from different parts of Finland. The main results from the previous FINRISK 2007 survey are published.The National FINRISK Study Survey was carried out in 5 areas in Finland and 2000 inhabitants aged 25-75 years were invited to participate in each year. Among findings were that Finns continue to gain weight.Data from FINRISK surveys are used for many different research projects and for national health monitoring needs. The recent research activities deal, in addition to cardiovascular diseases and the classical risk factors, also with e.g. asthma and allergy, alcohol, socioeconomic factors and genetic epidemiology.The FINRISK study is part of the MORGAM Project (MONICA Risk, Genetics, Archiving and Monigraph), sponsored by the EU and MDECODE (Molecular Diversity and Epidemiology of Common Disease) program coordinated by the University of Michigan.The exome sequencing study will be part of the Dilgom study, which is a part of the larger Finrisk population based health study performed in Finland. It consists of 5000 individuals with a prospective aspect of metabolic traits. The cohort has been extensively phenotyped for their cardiovascular and metabolic status. So far, we have performed a 660K Illumina GWAS and a full genome wide expression study from peripheral blood cells of 500 individuals. The cohort has also been in total genotyped by the cardiometabochip

  Study EGAS00001000086

• Whole genome sequencing dataset of 200 trio families from the CHILD cohort study.

  Study EGAS00001006725

• Acral melanoma study whole exomes

  Acral melanoma study whole exomes

  Dataset EGAD00001000061

• Study on longer adjuvant chemotherapy in Women with Early Breast Cancer

  The Cancer and Leukemia Group B (CALGB) 40101 trial compared four and six cycles of AC or single-agent paclitaxel in early breast cancer. The study was a 2X2 factorial design trial that also examined the effects of AC vs singleagent paclitaxel.

  Study phs000807

• Study of Leukemia Stem Cells in B-ALL

  This study focused on the biologic properties of human B acute lymphoblastic leukemia (ALL) stem cells. We used human leukemia cell lines, primary patient specimens, and patient derived xenografts in experiments using ChIP-seq, bulk RNA sequencing, single cell RNA sequencing, and CITE-seq.

  Study phs002492

• WTCCC case-control study for Bipolar Disorder - Combined Controls

  WTCCC genome-wide case-control association study for Bipolar Disorder (BD) using six disease collections together with the 1958 British Birth Cohort and the UK National Blood Service collections as controls.

  Study EGAS00000000002

• Exome sequencing study of cells derived from QHJI14s04 human iPSC secondary cell stock

  Genomic abnormalities of cells used in regenerative medicine should be checked. This study evaluates variants on coding sequences of cells derived from QHJI14s04 human iPSC secondary cell stock. Here we conducted whole exome sequence of three vials from the stock.

  Study EGAS50000000934

• Oxel Pilot Study

  This pilot study will provide preliminary data regarding the role of a peripheral immunoscore (PIS) in predicting the benefit of immune checkpoint inhibition with or without chemotherapy for high risk patients with triple-negative breast cancer (TNBC) and residual disease after effective neoadjuvant chemotherapy.

  Study EGAS50000000222

• A first-in-human clinical study of an allogenic iPSC-derived corneal endothelial cell substitute transplantation for bullous keratopathy

  iPSC-derived corneal endothelial cell substitutes recover pathological corneal edema. No adverse reactions are observed after one year follow-up. Gene mutations may appear despite whole genome sequencing of the master cell bank. This study contains WGS data.

  Study EGAS50000000672

• Study of tumor RNA expression differences between treated and untreated PitNET patients

  The goal of the study is to evaluate response of PitNET to drug therapy before surgery. Patients with and without drug therapy are compared in RNA level. The RNA is extracted from surgery material, sequenced and deferentially expressed genes (DEG) determined.

  Study EGAS00001004736